³Ô¹ÏÍøÕ¾

Latest monoclonal antibodies News

Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
hMPV may be spreading in China. Here’s what to know about this virus – and why it’s not cause for alarm
Scientists Discover New Receptor for Nerve Growth Factor-a Promising Target for Treating Pain
Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO – September/October 2024
Government’s free RSV immunisations will keep babies out of hospital: RACGP
Virtual screening IDs potential small molecule drugs for cancer immunotherapy
GPs commend Victorian Government for taking action on RSV
Protecting Victorian Newborns And Infants Next Winter
Research backs RACGP calls for ‘living’ long COVID guidelines
Center for NextGen Therapeutics helps match researchers to molecules
RSV is linked to asthma in children – but we can’t say one causes the other yet
Epitope Binning-seq: A Game-Changer in Antibody Drug Discovery Researchers pioneer a novel method, enabling simultaneous analysis of multiple antibodies, revolutionizing drug discovery…
Telix completes proof-of-concept study of TLX592 in prostate cancer
Future Cancer Treatment And Fertility
Babies in WA will soon be immunised against RSV – but not with a vaccine
Springfield Steps Up To Fight Breast Cancer
Promising Development for Breast Cancer Patients
Australian scientist recognised as emerging talent
WHO endorses landmark public health decisions on Essential Medicines for Multiple Sclerosis
Alzheimer’s drug donanemab has been hailed as a ‘turning point’ for treatment. But what does it mean for people with the disease?
Nirsevimab unanimously recommended by FDA Advisory Committee for the prevention of RSV lower respiratory tract disease in infants
WHO and Republic of Korea sign landmark agreement to boost biomanufacturing capacity
Wonder drug-capsule may one day replace insulin injection for diabetics
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
Antibody targets omicron and other SARS-CoV-2 variants
Update on effectiveness of monoclonal antibodies against COVID variants
New tool in arsenal against Covid is being put to t
Monash University and Ono Pharmaceutical Announce Collaboration Agreement
What are skeletal related events?
Beyfortus approved in EU for prevention of RSV lower respiratory tract disease in infants
New Omicron subvariant largely evades neutralizing antibodies
Evusheld long-acting antibody combination approved in EU for treatment of Covid
Evusheld long-acting antibody combination recommended for approval in EU for treatment of Covid
Beyfortus recommended for approval in EU by CHMP for prevention of RSV lower respiratory tract disease in infants
Evusheld long-acting antibody combination approved for prevention and treatment of Covid in Japan
RSV prevention finally in reach after 20 years of research at Telethon Kids Institute
WHO makes new recommendations for Ebola treatments, calls for improved access
Lack of innovation set to undermine antibiotic performance and health gains
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against Covid
TGA receives application for an increased dose of GlaxoSmithKline’s Covid treatment sotrovimab for BA.2 Omicron sublineage
Promising nose spray could prevent and treat Covid
AstraZeneca’s antibody combination, Evusheldâ–¼ authorised for use
New hope for babies born with heart defect
Sotrovimab shown to cause Covid treatment-resistant mutations
AstraZeneca’s Evusheld Granted Provisional Approval For Pre-Exposure Prophylaxis Of Covid
TGA provisionally approves AstraZeneca’s combination therapy – for pre-exposure prevention of Covid
Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants
Study Reveals How Migraine Pain Signals Are Generated-and Blocked